Trial
NCT02227784
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Hyperlipidemia
Intervention
Evacetrapib
Why stopped
Study termination due to program termination.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-08